Elutia
ELUT0.83752.79% ( -0.0240 )
Elutia (ELUT)
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The...
- Open
- 0.8790
- High
- 0.8799
- Low
- 0.8086
- Prev. Close
- 0.8615
- Volume
- 33.58K
- Turnover
- 28.77K
- Avg Price
- 0.8565
- Bid/Ask Ratio
- --
- Amplitude
- 8.28%
- 52wk High
- 1.3850
- Volume Ratio
- 0.60
- Turnover Ratio
- 0.11%
- 52wk Low
- 0.5000
- Float Mkt Cap
- 24.69M
- Market CapUSD
- 37.09M
- P/ETTM
- 0.72
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- 1.17
- EPSDynamic
- -0.683
- EPSStatic
- --
- BVPS
- 0.36
- P/B
- 2.36
- Circulating Supply
- 29.48M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 44.29M
- Min lot size
- 1
- Currency
- USD
Elutia Analyst Rating
View moreForecast & Rating
Oct 5, 2026Price forecast
$5.00497.01%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT ·
Elutia Schedules Third-Quarter Financial Results Release
- Global Report ·
Biotech Underdogs' Equity Gambit as Wall Street Eyes Double-Digit Upside
- benzinga_article ·
12 Health Care Stocks Moving In Friday's Pre-Market Session
- StockTitan ·
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029 | ELUT Stock News
- benzinga_article ·
12 Health Care Stocks Moving In Thursday's After-Market Session
